| Drug Maker Wins Notable Approval As It Seeks to Scale Internationally |
|
| From record-breaking dividend streaks to double-digit upside potential, this week's income plays pack both yield and growth.
Here's your rundown of the dividend movers every investor should have on their watchlist now. |
|
| | | | Hidden Setup (Sponsored) | | | We're tracking a small-cap setup that's slipping past most radars.
The fundamentals are lining up: | | Yet it's still trading like no one's paying attention.
That won't last.
[See the full report here]
(Free access while it's still under the radar.) | P.S. By the time setups like this make headlines, the early edge is gone. Don't wait.
(By clicking the link above, you agree to receive emails from MarketPulseToday. You can opt out at any time. - Privacy Policy) |
|
| | Pharmaceuticals | Eli Lilly Targets Next Wave of Obesity Therapies in $1.3B Superluminal Deal | | Eli Lilly (NYSE: LLY) has struck a $1.3 billion research and development agreement with Superluminal Medicines to discover small-molecule drugs targeting G protein-coupled receptors (GPCRs) in the cardiometabolic and obesity space.
The move gives Lilly exclusive rights to develop and commercialize compounds identified through Superluminal's AI and machine learning platform, a technology designed to uncover untapped therapeutic targets. | The partnership comes as Lilly's obesity and diabetes portfolio, led by Mounjaro and Zepbound, continues to deliver record-breaking revenue.
In the second quarter alone, the two drugs generated $8.57 billion.
By expanding into GPCR-based therapies, Lilly aims to diversify beyond its current focus on dual GIP/GLP-1 agonists, potentially unlocking new mechanisms for treating metabolic diseases. | For investors, the agreement signals Lilly's intention to maintain leadership in one of the fastest-growing pharmaceutical markets.
The deal could extend the company's growth runway well beyond the current lifecycle of its flagship products, while also positioning it to counter competitive advances from Novo Nordisk and other major players. | Potential entrants to the stock will watch closely for early-stage development updates that could validate this approach and set the stage for another high-revenue franchise. | LLY currently trades at $690 and pays a dividend of $6.00 per share, a yield of 0.87%. |
|
| | Logistics | UPS Signs 3-Year Deal to Boost High-Sensitivity Shipping Capabilities | | United Parcel Service (NYSE: UPS) has entered into a three-year partnership with PeriShip Global, a subsidiary of VerifyMe, aimed at enhancing digital integration and reliability in high-value, time-sensitive deliveries.
The agreements provide PeriShip with access to UPS services at promotional rates, along with advanced tools for shipment monitoring, weather tracking, and issue resolution through UPS's digital platforms. | The deal also allows PeriShip to integrate directly with UPS APIs, enabling the development of customized interfaces tied into UPS Access services.
This technology-driven approach to enhance transparency, speed, and control in sectors such as perishables, pharmaceuticals, and specialty goods. | For investors, the move reflects UPS's strategic focus on premium logistics markets with higher service requirements and more substantial margins.
Potential entrants will be watching how well the company can scale these enhanced capabilities into a broader revenue stream while differentiating itself from competitors in an increasingly tech-driven logistics sector. | The coming quarters will show whether UPS can turn its digital investments into sustained growth in high-value delivery segments, potentially strengthening its position in both market share and customer loyalty. | UPS currently trades at $88.00 and pays a dividend of $6.56 per share, a yield of 7.42%. |
|
| | Policy Winners: 4 Revealed (Sponsored) | | | Policy is no longer just politics—it's market strategy.
With U.S. manufacturing, defense, and energy getting a boost, select stocks are entering a unique window for growth. | This free report reveals 4 stocks that are flying under the radar now but could be front and center soon.
They're backed by real trends, not hype. | Get a clean breakdown, expert-selected picks, and two additional investor resources—all at no cost. | Click to access your copy and stay ahead while others react.
(By clicking the links above, you agree to receive future emails from StockAlertDaily. You can opt out at any time. - Privacy Policy) |
|
| | Infrastructure Investment | BlackRock's $11B Saudi Gas Deal Could Redefine Energy Infrastructure Investing | | BlackRock (NYSE: BLK) has agreed to a $11 billion, 20-year lease-and-leaseback transaction for natural gas processing facilities in Saudi Arabia's Jafurah basin.
The investment group, led by BlackRock's Global Infrastructure Partners unit, will hold a 49% stake in the new Jafurah Midstream Gas Company, while Saudi Aramco will retain a 51% stake. | The arrangement gives Aramco continued operational control while injecting foreign capital into one of the kingdom's most strategic energy assets.
For investors, this move reinforces BlackRock's ability to position itself at the intersection of energy security, infrastructure growth, and long-duration cash flow assets. | This deal offers a stable income profile through contracted returns, exposure to one of the world's largest natural gas reserves, and an entry point into the Middle East's expanding midstream sector.
It also signals BlackRock's readiness to participate in regional energy diversification efforts, which could lead to further partnerships. | While geopolitical and commodity price volatility remain inherent risks, the asset-backed nature of the agreement, combined with Aramco's operational scale, offers a defensive quality that may appeal to income-focused and infrastructure-oriented investors. | For potential entrants, the transaction highlights BlackRock's shift toward tangible, yield-generating assets, a move that comes at a time when market uncertainty is driving capital toward tangible assets.
As production in Jafurah ramps up later this year, the partnership will test the scalability of Saudi Arabia's foreign investment model and BlackRock's ability to leverage regional deals into broader global infrastructure leadership. | BLK currently trades at $1,150 and pays a dividend of $20.84 per share, a yield of 1.82%. |
|
| | Dividend Stocks Worth Watching | Outfront Media (NYSE: OUTFRONT) is a U.S. REIT specialising in outdoor and transit advertising. Its 6.54% dividend yield stands far above the S&P 500's average, making it an appealing choice for income-focused investors. | Although the payout hasn't increased recently, the company's steady quarterly distributions and ongoing transit advertising contracts provide a reliable revenue base. While headline revenue dipped year-over-year due to strategic asset sales, its core transit segment continues to expand. Technical analysis points to a potential 9.1% upside, with chart patterns showing a bullish cup-with-handle formation. | AbbVie (NYSE: ABBV) is a dividend titan with no less than 53 consecutive years of dividend increases in its history. The company has just announced a $195 million investment plan for its North Chicago, Illinois, manufacturing plant. The investment will be used to expand domestic active pharmaceutical ingredient (API) production in the U.S. | As another feather in its cap, the drugmaker's ELAHERE (mirvetuximab soravtansine) treatment has recently received UK marketing authorization as a treatment for platinum-resistant ovarian cancer. It's the first new treatment licensed for this condition in a decade. ABBV currently pays a $1.64 dividend with a 3.20% yield. | 3M (NYSE: MMM) is up 24% this year and is one of the best-performing companies in the DOW. The consumer, safety, and industrial products manufacturer pays a 73-cent dividend with a yield of 1.90%. | It has just celebrated the 100th anniversary of its Scotch™ Brand adhesive solutions and has increased its full-year EPS guidance following strong Q2 results. | | Dividend Increases | | | MDU has raised its dividend payment by 7.69% to 14 cents per share. Its new yield is 3.37%. | UCB has increased its dividend payment to 25 cents per share, a rise of 4.17%. Its new yield is 3.17%. | VRTS has lifted its dividend payment to $2.40, an increase of 6.67%. Its new yield is 4.86%. |
| |
|
| Dividend Decreases | | | | | CRI has slashed its dividend payment to 25 cents per share, a drop of 68.75%. Its new yield is 3.8%. | WILC has cut its dividend payment to 42 cents per share, a decrease of 28.94%. Its new yield is 0.9%. | WPP has decreased its dividend payment to 50 cents per share, a decline of 48.26%. Its new yield is 10.6%. |
| |
| | |
| | Untapped Potential Plays (Sponsored) | | | Right now, market attention is fixated on the usual big names — but that's not where we're seeing the most compelling setups.
We've uncovered seven companies with strong fundamentals and growing market share that most investors haven't noticed yet.
This is the kind of quiet strength that often leads to explosive moves.
We've put all the details in a free report so you can review them before the spotlight arrives.
[Get the report instantly] | (By clicking the link above, you will get this free report and a free subscription to MarketBeat's daily email newsletter. You are also agreeing to the terms of our privacy policy. Unsubscribe at any time.) |
|
| | Poll: You're given the chance to make one wealth-building move with zero risk. Which do you take? | | | Upcoming Dividend Payers | AMP's ex-dividend date for the forthcoming $1.60 payout is 08/18/25. | CALM's ex-dividend date for the forthcoming $2.35 payout is 08/19/25. | CAT's ex-dividend date for the forthcoming $1.51 payout is 08/20/25. | | | | That's all for today's edition of the Dividend Brief.
Thanks for reading, and if you have any feedback or dividend stocks you want me to take a look at, just reply to this email!
—Noah Zelvis
DividendBrief.com |
|
